FDA Approves Second Booster Dose
On Tuesday, March 28th, the US Food and Drug Administration approved a second booster dose of the Pfizer-BioNTech or Moderna Covid-19 vaccines out of a concern for a potential surge in cases due to the BA.2 variant. It is to be available to all adults 50 years or older as well as immunocompromised individuals, four months after their first booster.
Kimberly Bonvissuto writes a comprehensive article about it in the March 30th edition of McKnight Senior Living.
This article is for informational purposes only and does not provide legal advice. Please do not act or refrain from acting based on anything you read here. Please review the full disclaimer for more information. Relying on the information provided in this article or communicating with Lowndes through our website does not create an attorney/client relationship.
